Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21087590 | 0.97 | MGLL (0.45) | MGLL | |
| SCHEMBL21087653 | 0.75 | MGLL (0.50) | MGLL | |
| SCHEMBL25056690 | 0.69 | MGLL (0.40) | MGLL | |
| SCHEMBL31403133 | 0.67 | — | — | |
| SCHEMBL20050137 | 0.67 | MGLL (0.45) | MGLL | |
| SCHEMBL22436097 | 0.61 | MGLL (0.33) | MGLL | |
| SCHEMBL5965068 | 0.60 | MGLL (0.92) | MGLL | |
| SCHEMBL10959852 | 0.60 | MGLL (0.53) | MGLL | |
| SCHEMBL5337164 | 0.58 | MGLL (0.60) | MGLL | |
| SCHEMBL18949241 | 0.58 | MGLL (0.60) | MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10615456-B2 | Additive for nonaqueous electrolyte solutions, nonaqueous electrolyte solution and electricity storage device | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| US-10573929-B2 | — | — | 2020-02-25 | — | — | US | disclosed |
| US-20190181499-A1 | ADDITIVE FOR NONAQUEOUS ELECTROLYTE SOLUTIONS, NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10615456-B2 | Additive for nonaqueous electrolyte solutions, nonaqueous electrolyte solution and electricity storage device | SLC9A1, SLC26A3, SCNN1A | MGLL 3002/4885 |
| US-10573929-B2 | — | SLC26A3, SLC9A1, CLIC1 | MGLL 3319/4885 |
| US-20190181499-A1 | ADDITIVE FOR NONAQUEOUS ELECTROLYTE SOLUTIONS, NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE | SLC9A1, SLC26A3, SCNN1A | MGLL 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.